The Valley Desk

NCT06868212 · Interventional trial

A Study to Evaluate Efficacy of Remibrutinib Compared to Dupilumab at Early Timepoints in Adults With Chronic Spontaneous Urticaria Inadequately Controlled by Second Generation H1-antihistamines

Overall registry status Active not recruiting

Phase 3

Conditions Chronic Spontaneous Urticaria (CSU)

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov